OptiBiotix Health PLC OPTI
LSE · United Kingdom · Health Technology
GBp 5.850.00 (0.00%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
OptiBiotix Health PLC (AIM:OPTI, OTCQB:OPTBF), the AIM-listed life sciences company developing gut microbiome products and healthy sugar substitutes, saw its shares jump 13.5% to 5.68p after announcing plans to demonstrate its SweetBiotix products to shareholders at a London event in...
OptiBiotix Health PLC (AIM:OPTI, OTCQB:OPTBF) shares rose 10% to 6.42p on Tuesday after the life sciences group said it had no current intention to sell its 5.64% stake in SkinBioTherapeutics following market uncertainty caused by recent statements from the skincare company. OptiBiotix also...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.